139 related articles for article (PubMed ID: 10936883)
1. Roles for lipoprotein lipase in Alzheimer's disease: an association study.
Baum L; Wiebusch H; Pang CP
Microsc Res Tech; 2000 Aug; 50(4):291-6. PubMed ID: 10936883
[TBL] [Abstract][Full Text] [Related]
2. A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology.
Blain JF; Aumont N; Théroux L; Dea D; Poirier J
Eur J Neurosci; 2006 Sep; 24(5):1245-51. PubMed ID: 16965549
[TBL] [Abstract][Full Text] [Related]
3. LDL receptor-related protein (LRP) in Alzheimer's disease: towards a unified theory of pathogenesis.
Van Uden E; Kang DE; Koo EH; Masliah E
Microsc Res Tech; 2000 Aug; 50(4):268-72. PubMed ID: 10936878
[TBL] [Abstract][Full Text] [Related]
4. Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease.
Pritchard A; Harris J; Pritchard CW; St Clair D; Lemmon H; Lambert JC; Chartier-Harlin MC; Hayes A; Thaker U; Iwatsubo T; Mann DM; Lendon C
Neurosci Lett; 2005 Jul; 382(3):221-6. PubMed ID: 15925094
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein lipase mutations and Alzheimer's disease.
Baum L; Chen L; Masliah E; Chan YS; Ng HK; Pang CP
Am J Med Genet; 1999 Apr; 88(2):136-9. PubMed ID: 10206232
[TBL] [Abstract][Full Text] [Related]
6. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
7. Lack of association of two lipoprotein lipase polymorphisms with Alzheimer's disease.
Martin-Rehrmann MD; Cho HS; Rebeck GW
Neurosci Lett; 2002 Aug; 328(2):109-12. PubMed ID: 12133567
[TBL] [Abstract][Full Text] [Related]
8. Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease.
Depboylu C; Lohmüller F; Du Y; Riemenschneider M; Kurz A; Gasser T; Müller U; Dodel RC
Neurosci Lett; 2006 Jun; 400(3):187-90. PubMed ID: 16650578
[TBL] [Abstract][Full Text] [Related]
9. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
[TBL] [Abstract][Full Text] [Related]
10. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
Cui T; Zhou X; Jin W; Zheng F; Cao X
Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
[TBL] [Abstract][Full Text] [Related]
11. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease.
Raygani AV; Rahimi Z; Kharazi H; Tavilani H; Pourmotabbed T
Neurosci Lett; 2006 Nov; 408(1):68-72. PubMed ID: 16997467
[TBL] [Abstract][Full Text] [Related]
12. Associations of lipoprotein lipase S447X and apolipoprotein E genotypes with low-density lipoprotein subfractions in Turkish patients with coronary artery disease.
Aydogan HY; Isbir S; Kurnaz O; Gormus U; Isbir T
In Vivo; 2009; 23(1):155-61. PubMed ID: 19368142
[TBL] [Abstract][Full Text] [Related]
13. Genetic-morphologic association study: association between the low density lipoprotein-receptor related protein (LRP) and cerebral amyloid angiopathy.
Christoforidis M; Schober R; Krohn K
Neuropathol Appl Neurobiol; 2005 Feb; 31(1):11-9. PubMed ID: 15634227
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease.
Bahia VS; Kok F; Marie SN; Shinjo SO; Caramelli P; Nitrini R
Alzheimer Dis Assoc Disord; 2008; 22(1):61-5. PubMed ID: 18317248
[TBL] [Abstract][Full Text] [Related]
15. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
[TBL] [Abstract][Full Text] [Related]
16. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
[TBL] [Abstract][Full Text] [Related]
17. Use of haplotype information to test involvement of the LRP gene in Alzheimer's disease in the French population.
Verpillat P; Bouley S; Campion D; Hannequin D; Dubois B; Belliard S; Puel M; Thomas-Antérion C; Agid Y; Brice A; Clerget-Darpoux F
Eur J Hum Genet; 2001 Jun; 9(6):464-8. PubMed ID: 11436129
[TBL] [Abstract][Full Text] [Related]
18. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
19. [Study of relationship between ApoE epsilon4 allele and hippocampal atrophy in Alzheimer disease].
Li J; Kuang WH; Li J; Wang X; Huang MS; Wu DP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):50-2. PubMed ID: 15702779
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
